Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy, Safety and Patient-Reported Outcomes of Mirogabalin in Diabetic Peripheral Neuropathic Pain

NCT07451431 is registered in ClinicalTrials.gov with Bangladesh Medical University as lead sponsor.

NCT NCT07451431
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07451431 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy, Safety and Patient-Reported Outcomes of Mirogabalin in Diabetic Peripheral Neuropathic Pain
Lead sponsor
Bangladesh Medical University
Phase
Phase 4
Overall status
Recruiting
Start date
October 1, 2025
Completion date
May 31, 2027
Enrollment
78 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic peripheral neuropathic pain (dpnp)